MTD Stock Analysis: Buy, Sell, or Hold?
MTD - Mettler-Toledo International
$1274.05
12.85 (1.02%)
▲
5d:
+0.66%
30d:
-3.24%
90d:
-9.92%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
MTD is down 3.0% this week, but smart money is accumulating calls. Top strike: $1350 2026-04-17 with 5 OI. Call ratio: 65% View Scanner →
Strength: 3.0/10
Get Alerted When MTD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MTD trading at deep discount. Market pricing in -4.4% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: MTD trading at deep discount. Market pricing in -4.4% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1797.20
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1115.92
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MTD is currently trading at $1274.05, which is considered fair relative to its 30-day fair value range of $1198.45 to $1329.66. From a valuation perspective, the stock is trading at a discount (Forward PE: 24.9) compared to its historical average (28.5). Remarkably, the market is currently pricing in an annual earnings decline of 4.4% over the next few years. This pessimistic expectation contrasts with the company's recent 17.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, MTD is in a strong downtrend. The price is approaching resistance at $1299.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MTD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1505.23 (+18.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MTD is in a strong downtrend. The price is approaching resistance at $1299.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MTD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1505.23 (+18.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1198.45 -
$1329.66
Company Quality Score
56/100
(HOLD)
Options IV Signal
32th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
78.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 32th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($1505.23)
Fair Price Analysis
30-Day Fair Range
$1198.45 -
$1329.66
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$66.40
(5.2%)
Support & Resistance Levels
Support Level
$1174.50
Resistance Level
$1299.99
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.89
Wall Street Target
$1505.23
(+18.1%)
Revenue Growth (YoY)
8.1%
Earnings Growth (YoY)
17.0%
Profit Margin
21.6%
Valuation Discount vs History
-4.4% cheaper
PE vs Historical
24.9 vs 28.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.4%
(market-implied from PE analysis)
1-Year Target
$1217.99
(-4%)
2-Year Target
$1164.40
(-9%)
3-Year Target
$1113.17
(-13%)
3-Yr Target (if PE normalizes)
(PE: 25→29)
$1274.63
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.9, Growth: 10.1%)
$1698.98
(+33%)
Base:
(SPY PE: 22.4, Growth: 10.1%)
$1525.61
(+20%)
Bear:
(PE: 19.0, Growth: 10.1%)
$1296.77
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 28.65 | Current EPS (TTM): $42.04
Bull Case
$1613.22
(+30%)
Analyst growth 21.8%, PE expands to 31.5
Base Case
$1466.56
(+18%)
Market implied 21.8%, PE stable at 28.7
Bear Case
$819.05
(-34%)
Severe decline -20.0%, PE contracts to 24.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.9 to 28.5
Stabilization Target:
$1458.84
(+14.5%)
PE Expansion Potential:
+14.5%
Share & Embed Analysis
Last updated: April 02, 2026 5:59 AM ET
Data refreshes hourly during market hours. Next update: 6:59 AM
Data refreshes hourly during market hours. Next update: 6:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Shawn Vadala
SELL
800 shares
2026-02-10
Julia Letlow
SELL
2025-12-08
La Guerroniere Marc De
SELL
6055 shares
2025-11-25
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 66 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 66 BUY |
Advanced MTD Option Strategies
Professional options setups generated by AI based on today's MTD price and gamma walls.
